MedPath

Effect of Fruit and Vegetable Concentrates on Endothelial Function in Persons With Metabolic Syndrome

Phase 1
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: Blend 2
Dietary Supplement: Placebo
Dietary Supplement: Blend 1
Registration Number
NCT01224743
Lead Sponsor
Griffin Hospital
Brief Summary

Dehydrated fruit and vegetable concentrates provide an accessible form of phytonutrient supplementation that may offer cardioprotective effects. This study assessed the effects of encapsulated fruit and vegetable juice powder concentrates on endothelial function and cardiac risk markers in subjects in a randomized, double blind, placebo controlled crossover clinical trial with three treatment arms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • metabolic syndrome defined by AHA/NHLBI criteria
  • nonsmoker
  • not taking any other vitamins or dietary supplements
  • able to have blood pressure measured bilaterally at the brachial artery
Exclusion Criteria
  • any unstable medical condition that would limit the ability to participate fully in the trial
  • rheumatologic disease requiring regular use of NSAIDs
  • preexisting cardiovascular disease
  • diagnosed eating disorder
  • inability to complete endothelial function assessment.
  • use of insulin, glucose sensitizing medication, vasoactive medications (including glucocorticoids, antineoplastic agents, psychoactive agents, or bronchodilators), nutriceuticals, fiber supplements, and tobacco.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Blend 2Blend 2Blend 2 - combination of Juice Plus+® Orchard (Fruit) and Garden (Vegetable) blends
PlaceboPlaceboPlacebo capsules are provided by the study sponsor and are identical in appearance to active treatments to ensure blinding.
Blend 1Blend 1Blend 1 - combination of Juice Plus+® Orchard (Fruit), Garden (Vegetable), and Vineyard (Berry) blends
Primary Outcome Measures
NameTimeMethod
Endothelial Function8-weeks

Endothelial function as flow-mediated dilatation (FMD)

Secondary Outcome Measures
NameTimeMethod
Weight8-weeks

Measured on a calibrated scale

Lipid panel8-weeks

Total cholesterol, TG, HDL, LDL, ratio

Insulin8-weeks

Serum insulin

Trial Locations

Locations (1)

Griffin Hospital

🇺🇸

Derby, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath